Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aquinox Pharmaceuticals (Canada) Inc.
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Be females, ≥18 and ≤75 years of age, who have consistently had symptoms of bladder pain in addition to urinary urgency and/or urinary frequency for more than 12 months
Have had the diagnosis of interstitial cystitis for \> 6 months (pain for at least 12 months) but ≤15 years
Have average daily pain score of at least 5 out of 10 on the 11-point Numerical Rating Scale \[NRS\] pain scale in the 9 days prior to baseline
Have undergone a cystoscopy and have documented visible signs of bladder bleeding, lesions or glomerulation within the last 36 months prior to baseline.
Subjects if of child bearing potential, must agree to avoid pregnancy and use medically acceptable method of contraception from screening visit and throughout the study.
Must be capable of voiding independently
You may not be if
Pelvic floor pain (\>5 out of 10 on the 11-point NRS pain scale following a pelvic pain assessment)
Have a body mass index \[BMI\] of \<18 kg/m2 or \>39 kg/m2
Have had a urinary tract infection including bacterial cystitis within the past 30 days.
Have greater than 1+ hematuria on dipstick test at screening from an unknown cause
History of previous procedure(s) (augmentation cystoplasty, cystectomy, or cystolysis) that has affected bladder function
